Johnson & Johnson
JNJ
#18
Rank
A$838.96 B
Marketcap
A$348.13
Share price
1.38%
Change (1 day)
37.60%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Earnings for Johnson & Johnson (JNJ)

Earnings in 2024: A$24.69 Billion

According to Johnson & Johnson's latest financial reports the company's current earnings are A$92.14 Billion. In 2024 the company made an earning of A$24.69 Billion, an increase over its 2023 earnings that were of A$22.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Johnson & Johnson from 1984 to 2024

Annual earnings

Year Earnings Change
2024A$24.69 B10.16%
2023A$22.42 B-25.84%
2022A$30.23 B-7%
2021A$32.51 B37.5%
2020A$23.64 B-5.37%
2019A$24.98 B-7.15%
2018A$26.91 B2.13%
2017A$26.34 B-9.36%
2016A$29.07 B3.95%
2015A$27.96 B-6.39%
2014A$29.87 B32.24%
2013A$22.59 B11.5%
2012A$20.26 B10.63%
2011A$18.31 B-25.69%
2010A$24.64 B7.38%
2009A$22.94 B-9.81%
2008A$25.44 B18.12%
2007A$21.54 B10.97%
2006A$19.41 B5.73%
2005A$18.36 B0.79%
2004A$18.21 B18.33%
2003A$15.39 B12.33%
2002A$13.70 B22.74%
2001A$11.16 B19.71%
2000A$9.32 B10.13%
1999A$8.46 B18.55%
1998A$7.14 B9.15%
1997A$6.54 B7.41%
1996A$6.09 B20.67%
1995A$5.04 B27.04%
1994A$3.97 B17.4%
1993A$3.38 B5.01%
1992A$3.22 B5.22%
1991A$3.06 B5.51%
1990A$2.90 B
1988A$1.98 B16.12%
1987A$1.71 B22.93%
1986A$1.39 B17.1%
1985A$1.18 B12.68%
1984A$1.05 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.15 B-49.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.78 B-63.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.52 B-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.07 B-80.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$31.86 B-30.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.88 B-71.91%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
A$13.99 B-69.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$4.72 B-89.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.69 B-28.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.20 B-71.22%๐Ÿ‡ฌ๐Ÿ‡ง UK